StockVS

Centene Corporation (CNC) 股票分析

医疗保健

Centene Corporation

$57.21

$-1.93 (-3.26%)

最后更新: 2026年5月26日

价格走势

最新新闻

新闻由第三方来源提供。不构成投资建议。

分析

公司概述

Centene Corporation operates within the healthcare sector as a managed care entity, delivering programs and services primarily to under-insured families and commercial organizations across the United States. The company's business model is segmented into four distinct areas, including Medicaid, Medicare, Commercial, and Other, with the Medicaid segment specifically offering temporary assistance initiatives. As of the latest data, the company holds a market capitalization of $18.47 billion and generates annual revenue of $176.15 billion, employing a workforce of 61,100 individuals. These valuation and revenue figures indicate that Centene functions as a major player in the healthcare plans industry, managing substantial assets and serving a vast customer base to support its operational scale.

财务健康

The company reported a trailing twelve-month revenue of $176.15 billion, yet this revenue generated a net income of -$6,673,999,872, highlighting a significant disparity between top-line sales and bottom-line profitability due to high operational costs. Despite the net loss, the entity maintained an EBITDA of $2.56 billion, which serves as a critical metric for assessing its operational cash generation capabilities independent of capital structure decisions. The free cash flow stands at $5.05 billion, providing the company with substantial financial flexibility to fund operations, reduce debt, or pursue strategic investments without immediate reliance on external financing. Profitability metrics further illustrate the cost pressures, with a gross margin of 10.5%, an operating margin of -1.9%, and a profit margin of -3.8%, indicating that operating expenses significantly erode gross profits before reaching the bottom line. On the balance sheet, Centene holds $20.32 billion in cash against $18.16 billion in debt, resulting in a debt-to-equity ratio of 90.56%, which suggests a highly leveraged capital structure where debt levels are nearly equal to equity. However, the current ratio of 1.10 indicates that the company possesses just enough liquid assets to cover its short-term liabilities, reflecting a tight but manageable liquidity position. Return on equity is recorded at -28.7% and return on assets at 1.0%, revealing that management has struggled to generate returns on shareholder equity and total assets over the measured period, primarily driven by the substantial net loss.

估值评估

The valuation metrics present a mixed picture, with a P/E ratio (TTM) listed as N/A due to the net loss, while the forward P/E is 9.21, implying that the market anticipates a significant improvement in earnings trajectory in the coming year. The price-to-book ratio stands at 0.93, indicating that the market values the company at roughly 93% of its book value, suggesting no premium and potentially a discount relative to its tangible assets. Alternative valuation measures provide further context, with a price-to-sales ratio of 0.10 and an EV/EBITDA of 6.41, which suggests the stock is priced at a fraction of its sales and generates low enterprise value relative to earnings before interest, taxes, depreciation, and amortization. In terms of trading range, the 52-week high is $66.03 and the 52-week low is $25.08, placing the current share price within this historical band and reflecting the recent volatility in the stock. The beta value of 0.59 indicates that the stock's price volatility is lower than that of the broader market, suggesting it may be less sensitive to general market fluctuations compared to large-cap technology or financial stocks.

Growth & Income

Revenue growth year-over-year is 23.2%, demonstrating a robust expansion in top-line sales, whereas earnings growth is N/A due to the reported net loss, indicating that earnings are currently not growing in tandem with revenue and remain suppressed by cost structures. The company does not distribute dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, meaning the firm retains all earnings rather than distributing them to shareholders. This reinvestment strategy implies that the company prioritizes funding internal growth initiatives and debt management over providing immediate income returns to investors. Overall, Centene's profile is characterized by strong revenue expansion and significant free cash flow generation, though it currently lacks profitability and dividend income, presenting a distinct risk-reward dynamic for investors focused on growth versus income.

同行比较

Centene Corporation (CNC) 在医疗保健计划行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Centene Corporation CNC $28.25B N/A
UnitedHealth Group Incorporated UNH $342.24B 28.4
CVS Health Corporation CVS $115.76B 39.8
Elevance Health, Inc. ELV $84.23B 16.4

医疗保健计划行业平均市盈率为45.1倍。Centene Corporation的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Centene Corporation

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

公司简介以英文显示。

访问官网 →

关键指标

市值
$28.25B
市盈率
N/A
52周最高
$60.76
52周最低
$25.08
平均成交量
6.51M
Beta系数
1.06

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NYSE
国家
United States
员工数
61,000